Human Vaccines & Immunotherapeutics (Apr 2021)

Vaccination for Human Papillomavirus: an historic and bibliometric study

  • Sébastien Bruel,
  • Dominique Dutzer,
  • Marion Pierre,
  • Elisabeth Botelho-Nevers,
  • Bruno Pozzetto,
  • Amandine Gagneux-Brunon,
  • Franck Chauvin,
  • Paul Frappé

DOI
https://doi.org/10.1080/21645515.2020.1805991
Journal volume & issue
Vol. 17, no. 4
pp. 934 – 942

Abstract

Read online

A systematic literature review was conducted to describe in a historical perspective the evolution of studies concerning HPV vaccination. The search identified 794 articles of which 568 were included. The first article was published in 2001, and the maximum annual number of publications was reached in 2014. The average number of authors per paper was 8.8. Papers originated from 49 different countries, with the USA accounted for the maximum number of publications (n = 217). Efficacy (46.5%) and safety (31.0%) were the most prevalent objectives. Clinical trials constituted the largest group of methods (37.9%). Chronological trends did not reveal any lasting curve-crossings, indicating that the priority topics have remained the same. The geographical origin of these studies raises questions about the transposability of the results to populations where HPV vaccination has been studied only a little. This study could help guide future research to less-studied research objectives, particularly for vaccines.

Keywords